Clinical Trials in San Antonio

Showing 5061-5080 of 11,125 trials

A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease

NCT01559363

The primary objective of this study Phase 1b was to determine the safety, plasma pharmacokinetics, and maximum tolerated dose (MTD) of tesevatinib when administered to participants with autosomal dominant polycystic kidney disease (ADPKD). The primary objective of this study Phase 2a was to evaluate the annualized change in glomerular filtration rate (GFR) in participants with ADPKD when treated with tesevatinib.

Polycystic Kidney, Autosomal Dominant

Kadmon, a Sanofi Company69 participantsStarted Oct 2012

Los Angeles, California, United States • Denver, Colorado, United States • Kansas City, Kansas, United States +8 more locations

COMPLETEDPhase 3< 1 mile

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

NCT00358215

The purpose of the study is to determine the efficacy of treatment of anemia with darbepoetin alfa compared to placebo on the composite of time to death from any cause or first hospital admission for worsening heart failure in patients with symptomatic left ventricular systolic dysfunction and anemia.

Heart FailureAnemiaCardiovascular Disease+2 more

Amgen2,278 participantsStarted Jun 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +751 more locations

A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Find Trials by Condition in San Antonio

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

The Effects of Hot Yoga on Vascular Function

Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

Blepharospasm Patient Survey for Patients With Blepharospasm